A phase three clinical trial is being conducted here to evaluate the safety and efficacy of a new quadrivalent dengue vaccine ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

Crimean-Congo hemorrhagic fever begins with nonspecific febrile symptoms and progresses to hemorrhagic syndrome. Infection typically progresses through four stages: incubation, pre-hemorrhagic ...

It is possible to distinguish between different hemorrhagic fevers, including Marburg (Ebola cousin) and Lassa before the person becomes symptomatic, new research has found. This study will allow ...

An ongoing Phase III clinical trial of DengiAll, a one-shot dengue vaccine developed by Panacea Biotec, is progressing in ...

Hemorrhagic fevers, which include Ebola, are a frightening group of illnesses, ... In the first phase there's rapid onset of high fever, headache, muscle pain, diarrhea and vomiting.

Mysterious Hemorrhagic Fever In South Sudan Stumps Disease Detectives : Goats and Soda There's fever. And unexplained bleeding. Like Ebola. But tests show that the 51 cases in South Sudan are ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...